Bite Me Cancer Foundation

Last updated

The Bite Me Cancer Foundation is a nonprofit 501(c) organization, founded in Fairfax County, Virginia, in September 2010 by Nikki Ferraro and her parents, Sharon Ferraro and C. Michael Ferraro. Bite Me Cancer was founded with the goal to support teenagers with all types of cancer, in addition to providing direct funding to research and improve awareness and advocacy for thyroid cancer. Bite Me Cancer partners with the American Thyroid Association to raise awareness and fund grants across the world. Bite Me Cancer seeks to both support teenagers with all types of cancer and directly fund for thyroid cancer research.

Contents

History

At the age of 17, Nikki Ferraro was diagnosed with sporadic medullary thyroid cancer, a rare form of thyroid carcinoma, in April 2010 as a junior at Chantilly High School, Chantilly, Virginia. Immediately following her diagnosis, she organized a Relay for Life team in support of her diagnosis, and two months later finished as the #1 individual fundraiser in South Atlantic Region of the American Cancer Society after raising over $20,000. Nikki was driven to take the support she received from the Relay experience and turn it into a widespread campaign to help others dealing with cancer. Three months later, in September 2010, Bite Me Cancer was incorporated into a foundation.

Two months after the formation of Bite Me Cancer, Nicole Ferraro received the 2010 Leadership Fairfax Non-Profit Educational Leadership Award. [1] The following year, she received the first-ever Perlita Liwanag Scholarship from the Ulman Cancer Fund for Young Adults at Chantilly High School. [2] Bite Me Cancer focuses on supporting teens undergoing cancer treatment, in addition to supporting the progression of thyroid cancer research and treatment development. [3]

Bite Me Cancer, with Nikki’s leadership, developed its Teen Support Bag and handed out the first one in 2012. It was and still is important that the items are chosen specifically for teen cancer patients. Teenagers dealing with cancer fall through the cracks between the younger pediatric patients and adult patients. They need much support as they face unique challenges.

When Nikki was diagnosed, thyroid cancer was the fastest increasing cancer in the US with very few treatment options. In her case, surgery was the only available treatment. Directly funding research grants became a high priority for Bite Me Cancer.

Teen Cancer Awareness Week

On July 31, 2014, Virginia Governor Terry McAuliffe declared the third week of January, starting in 2015, Teen Cancer Awareness Week in the Commonwealth of Virginia, [4] thanks to the hard work and determination of Ferraro and the Bite Me Cancer Foundation. McAuliffe stated in his declaration that "the health and safety of all Virginians is essential to the happiness and well-being of the Commonwealth’s families and communities, whereas cancer is the leading cause of death in the adolescent population, and whereas the survival rates for adolescent cancer have not improved in the last thirty years." The Fairfax County Board of Supervisors provided a proclamation for Teen Cancer Awareness Week in January 2015, and Bite Me Cancer officially announced on January 4, 2015, that the awareness week would begin the same year. [5] In his declaration, Governor McAuliffe also highlighted the fact that many teens battling cancer are "isolated from their friends and family," and noted the importance of "vigorously" supporting them as they return to everyday social and academic settings. [6] Bite Me Cancer continues to raise awareness in schools and homes with this annual event.

Thyroid cancer

Ferraro explains that many people refer to thyroid cancer as the "good cancer" due to the perception that there is not a high rate of mortality, its history of being diagnosed in a smaller group of people and that losing the thyroid is not a difficult situation. [7] However, thyroid cancer is dangerous and can be aggressive. Medullary thyroid cancer is rare, accounting for 3–4% of all thyroid cancer diagnoses. Currently, medullary thyroid cancer is noncurative, meaning that those diagnosed with this form of thyroid carcinoma will likely battle it for the rest of their lives. Less than a handful of drugs have been approved for medullary thyroid cancer treatment. [8]

Research

Bite Me Cancer has funded seven research grants for thyroid cancer in the past and is working toward funding another during 2021. The first grant, totaling $57,500, was awarded in 2014 to Ramona Dadu, MD at the MD Anderson Cancer Center in Houston, Texas. The two-year research project, titled "Immune Markers in Medullary Thyroid Cancer (MTC) and Their Clinical Significance", [9] and began in July 2014. Dadu is an assistant professor at Anderson Cancer Center in the Department of Endocrine Neoplasia & Hormonal Disorders. [10] Dadu also received the Women in Endocrinology Young Investigator Award and the American Thyroid Association Grant for her research in 2014. Dadu's research "will work with experts in the field of immunotherapy to uncover new information of prognosis and how medications interact with the cancer". [11] "The ultimate goal is to see that many patients will benefit from this approach." [12]

Fundraising

Bite Me Cancer organizes annual events, including an annual wine dinner (2014–present) every year to honor and celebrate with cancer survivors including Nikki Ferraro, who was diagnosed in April 2010. The focus on onsite donations during the dinner is to support our Teen Support Bag program. There are currently few programs in place to support teenagers with cancer, but there are thousands of programs to support young children and adults. Teenagers with cancers often require specific treatment and support, and there is very little awareness of the struggles that teenagers with cancer face. By developing and shipping the Teen Support Bags to hospitals around the country for their teenagers battling cancer and holding events to raise awareness, Bite Me Cancer is participating in a movement to increase support and make more resources available to these special teenagers. [13]

Teen Support Bags

As of June 2021, Bite Me Cancer has passed out 8,600 Teen Support Bags across the country to teens with cancer through a growing network of hospitals that enable teenagers in every state and DC to receive the bags. Currently, about 150 hospitals are part of the network. The foundation coordinates the stuffing and distribution of the Teen Support Bags every year with groups of volunteers. Each bag includes items to eliminate stress, inspire and support teenagers currently undergoing cancer treatment. Nikki Ferraro tries to hand-deliver the bags to teens, offering advice and encouragement during their treatments. [14]

Related Research Articles

<span class="mw-page-title-main">Calcitonin</span> Amino acid peptide hormone secreted by the thyroid gland

Calcitonin is a 32 amino acid peptide hormone secreted by parafollicular cells (also known as C cells) of the thyroid (or endostyle) in humans and other chordates in the ultimopharyngeal body. It acts to reduce blood calcium (Ca2+), opposing the effects of parathyroid hormone (PTH).

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

<span class="mw-page-title-main">The Brain Tumour Charity</span> British charity founded in 1996

The Brain Tumour Charity is a UK-based, Charity Commission registered, charity dedicated to funding research, raising awareness of brain tumours, reducing diagnosis times and providing support and information for people with brain tumours, their families and friends.

<span class="mw-page-title-main">Sally Satel</span> American psychiatrist

Sally L. Satel is an American psychiatrist based in Washington, D.C. She is a lecturer at Yale University School of Medicine, a visiting professor of psychiatry at Columbia University, a senior fellow at the American Enterprise Institute, and an author.

Relay For Life is a community-based walkathon fundraising event for the American Cancer Society. Each year, more than 5,000 Relay For Life events take place in over twenty countries. Events are held in local communities, university campuses and as virtual campaigns. As the American Cancer Society's most successful fundraiser and the organization's signature event, the mission of Relay For Life is to raise funds to improve cancer survival, decrease the incidence of cancer, and improve the quality of life for cancer patients and their caretakers.

<span class="mw-page-title-main">Anaplastic thyroid cancer</span> Medical condition

Anaplastic thyroid cancer (ATC), also known as anaplastic thyroid carcinoma, is an aggressive form of thyroid cancer characterized by uncontrolled growth of cells in the thyroid gland. This form of cancer generally carries a very poor prognosis due to its aggressive behavior and resistance to cancer treatments. The cells of anaplastic thyroid cancer are highly abnormal and usually no longer resemble the original thyroid cells and have poor differentiation.

The "war on cancer" is the effort to find a cure for cancer by increased research to improve the understanding of cancer biology and the development of more effective cancer treatments, such as targeted drug therapies. The aim of such efforts is to eradicate cancer as a major cause of death. The signing of the National Cancer Act of 1971 by United States president Richard Nixon is generally viewed as the beginning of this effort, though it was not described as a "war" in the legislation itself.

<span class="mw-page-title-main">Breast Cancer Research Foundation</span> Research organization

The Breast Cancer Research Foundation (BCRF) is an independent, not-for-profit organization which has raised $569.4 million to support clinical and translational research on breast cancer at medical institutions in the United States and abroad. BCRF currently funds over 255 researchers in 14 countries.

<span class="mw-page-title-main">Terry McAuliffe</span> Governor of Virginia from 2014 to 2018

Terence Richard McAuliffe is an American businessman and politician who served as the 72nd governor of Virginia from 2014 to 2018. A member of the Democratic Party, he was co-chairman of President Bill Clinton's 1996 reelection campaign, chairman of the Democratic National Committee from 2001 to 2005 and chairman of Hillary Clinton's 2008 presidential campaign.

<span class="mw-page-title-main">Prostate Cancer Foundation</span> American non-profit organization

The Prostate Cancer Foundation (PCF), headquartered in Santa Monica, California, funds research into the prevention and cure of prostate cancer.

<span class="mw-page-title-main">Thyroid cancer</span> Medical condition

Thyroid cancer is cancer that develops from the tissues of the thyroid gland. It is a disease in which cells grow abnormally and have the potential to spread to other parts of the body. Symptoms can include swelling or a lump in the neck. Cancer can also occur in the thyroid after spread from other locations, in which case it is not classified as thyroid cancer.

<span class="mw-page-title-main">Saul Hertz</span> American physician-scientist

Saul Hertz, M.D. was an American physician who devised the medical uses of radioactive iodine. Hertz pioneered the first targeted cancer therapies. Hertz is called the father of the field of theranostics, combining diagnostic imaging with therapy in a single or paired chemical substance(s).

The British Thyroid Foundation (BTF) is a UK-based, patient-led, registered charity dedicated to supporting people with thyroid disorders and helping their families and people around them to understand the condition.

<span class="mw-page-title-main">Cabozantinib</span> Chemical compound

Cabozantinib, sold under the brand names Cometriq and Cabometyx among others, is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc.

The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research and education institution with six locations in the St. Louis area. Siteman is the only cancer center in Missouri and within 240 miles of St. Louis to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Siteman is also the only area member of the National Comprehensive Cancer Network, a nonprofit alliance of 32 cancer centers dedicated to improving the quality and effectiveness of cancer care.

Ovarian Cancer Research Alliance (OCRA) is a not-for-profit organization focused on ovarian cancer research, advocacy and patient support. The organization was formed in January 2016 when the former not-for-profit organization Ovarian Cancer Research Fund, which focused primarily on ovarian cancer research, combined with Ovarian Cancer National Alliance, which focused primarily on ovarian cancer advocacy and support programs, to form one organization.

<span class="mw-page-title-main">Dulaglutide</span> Diabetes medication

Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors. It is a once-weekly injection.

<span class="mw-page-title-main">Side-Out Foundation</span> American non-profit organization

The Side-Out Foundation, located in Fairfax, Virginia, is an American non-profit breast cancer charity that raises awareness and funds for the treatment of metastatic breast cancer. Side-Out fundraises mainly through volleyball-related events. Their mission, as it is stated on their website is, "to unite volleyball players and coaches and to have them work toward the common goal of furthering breast cancer awareness, education, and patient services." Side-Out has a board of directors and team of scientific advisers.

The Virginia Cyber Range is an educational and research institute funded by a $4-million grant from the Commonwealth of Virginia to promote education in cybersecurity across the state. Currently, the Cyber Range is based out of the Virginia Tech Corporate Research Center.

<span class="mw-page-title-main">Julie Ann Sosa</span> American surgeon

Julie Ann Sosa is a professor and chair of the Department of Surgery at the University of California, San Francisco (UCSF) and holds the Leon Goldman, MD, Distinguished Professorship in Surgery. She currently serves as the Treasurer of the American Thyroid Association and Editor-in-Chief of the World Journal of Surgery.

References

  1. ↑ Rust, LeMunyon and Plum (January 12, 2011). "House Joint Resolution No. 670". Virginia House of Delegates. Archived from the original on April 2, 2015. Retrieved February 24, 2015.
  2. ↑ "Perlita Liwanag Memorial Scholarship". Ulman Fund. Ulman Fund. 2013. Archived from the original on May 16, 2014. Retrieved February 24, 2015.
  3. ↑ "Bite Me Cancer – About". Bite Me Cancer. Archived from the original on February 19, 2015. Retrieved February 20, 2015.
  4. ↑ McAuliffe, Terry (2015). "Teen Cancer Awareness Month". Virginia Governor's Office. Virginia Governor's Office. Retrieved February 24, 2015.[ permanent dead link ]
  5. ↑ "Board of Supervisors Meeting". Jan. 13, 2015 Board of Supervisors Meeting. Fairfax County, Virginia. January 13, 2015. Archived from the original on February 23, 2015. Retrieved Feb 20, 2015.
  6. ↑ "Proclamation – Teen Cancer Awareness Month". Virginia Governor's Office. January 13, 2015. Retrieved February 25, 2015.[ permanent dead link ]
  7. ↑ Ferraro, Nicole (Jan 27, 2013). "Thyroid Cancer: NOT The Good Cancer". YouTube. BiteMeCancerOrg. Archived from the original on July 26, 2024. Retrieved Feb 27, 2015.
  8. ↑ "Immune Markers in Medullary Thyroid Cancer (MTC) and Their Clinical Significance Preliminary Results" (PDF). MD Anderson Cancer Center. 2014. Archived from the original (PDF) on 2014-02-17. Retrieved Feb 24, 2015.
  9. ↑ "The American Thyroid Association Recognizes Research Grant Collaboration of Patient Support Groups Bite Me Cancer and ThyCa Thyroid Cancer Survivors Association Inc". American Thyroid Association. July 22, 2014. Archived from the original on July 26, 2024. Retrieved February 20, 2015.
  10. ↑ "Thyroid Cancer". American Cancer Society. Retrieved February 20, 2015.
  11. ↑ "Dr Dadu from MD Anderson and Bite Me Cancer's Research Grant Investment". YouTube. BiteMeCancerOrg. Jan 2, 2015. Archived from the original on March 9, 2016. Retrieved Feb 20, 2015.
  12. ↑ "Dr Dadu from MD Anderson and Bite Me Cancer's Research Grant Investment". YouTube. BiteMeCancerOrg. Jan 2, 2015. Archived from the original on March 9, 2016. Retrieved Feb 20, 2015.
  13. ↑ "Events". Bite Me Cancer. Archived from the original on February 19, 2015. Retrieved March 1, 2015.
  14. ↑ "BMC Teen Support". Bite Me Cancer. Bite Me Cancer. 2011. Archived from the original on March 20, 2015. Retrieved March 5, 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.